NPPA notified regarding the Computation of Retail Price of drug where each film coated bilayered tablet contains Linagliptin 2.5 mg + Metformin Hydrochloride IP 500 mg

Jun 25, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 24, 2024, issued the notification regarding the Computation of the Retail Price of the drug where each film-coated bilayered tablet contains Linagliptin 2.5 mg + Metformin Hydrochloride IP 500 mg.

The following has been stated namely: -

• The Computation of Retail Price is based Data from on October 2023

• The Retail price is calculated of Each Film coated bilayered tablet containing Linagliptin 2.5 mg + Metformin Hydrochloride IP 500 mg (as extended release) for M/s Synokem Pharmaceuticals Ltd. (Manufacturer)& M/s Cipla Ltd. (Marketer)

• The Total MAT is 8,15,35,180

[Notification No. 19(3975)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT